Cardiovascular Clinical Trials

Upon agreeing to participate in the study, you will be asked to sign an Informed Consent Form that provides comprehensive details about this peripheral artery disease clinical trial. Our research team will also guide you through the study process and explain your role in the trial. We strongly encourage participants to ask any questions they may have before deciding to participate or withdraw from the trial.

Once the consent form is signed and all questions are addressed, participants will be randomly assigned to one of two groups: the Control group or the Experimental group.

In the Control group, participants will receive a standard balloon angioplasty procedure, while those in the Experimental group will receive the investigational drug-coated balloon device. This study is double-blind, meaning neither the researcher nor the participant knows which treatment is being administered.

Study-related care is provided free of charge. Expert physicians and healthcare professionals will perform thorough physical exams and assessments throughout the trial.

Upon agreeing to participate in the study, you will be asked to sign an Informed Consent Form that provides comprehensive details about this heart failure treatment research study. Our research team will also guide you through the study process and explain your role in the trial. We strongly encourage participants to ask any questions they may have before deciding to participate or withdraw from the trial.

Once the consent form is signed and all questions are addressed, participants will be randomly assigned to one of three groups: the Control group or one of two Experimental groups.

In the Control group, participants will receive a placebo injection without active ingredients, while those in the Experimental groups will receive the actual investigational treatment at varying doses every two weeks. This study is double-blind, meaning neither the researcher nor the participant knows which treatment is being administered.

Study-related care is provided free of charge. Expert physicians and healthcare professionals will perform thorough physical exams and assessments throughout the trial.

Upon agreeing to participate in the study, you will be asked to sign an Informed Consent Form that provides comprehensive details about this hypertension clinical trial. Our research team will also guide you through the study process and explain your role in the trial. We strongly encourage participants to ask any questions they may have before deciding to participate or withdraw from the trial.

Once the consent form is signed and all questions are addressed, participants will be randomly assigned to one of two groups: the Control group or the Experimental group.

In the Control group, participants will receive a placebo without active ingredients, while those in the Experimental group will receive the actual investigational treatment. This study is double-blind, meaning neither the researcher nor the participant knows which treatment is being administered.

Study-related care is provided free of charge. Expert physicians and healthcare professionals will perform thorough physical exams and assessments throughout the trial.

Upon agreeing to participate in the study, you will be asked to sign an Informed Consent Form that provides comprehensive details about this hereditary hemochromatosis clinical trial. Our research team will also guide you through the study process and explain your role in the trial. We strongly encourage participants to ask any questions they may have before deciding to participate or withdraw.

Once the consent form is signed and all questions are addressed, participants will be randomly assigned to one of two groups: the Control group or the Experimental group.

In the Control group, participants will receive a placebo medication without active ingredients, while those in the Experimental group will receive the actual study drug containing active ingredients. This study is double-blind, meaning neither the researcher nor the participant knows which treatment is being administered.

Study-related care is provided free of charge. Expert physicians and healthcare professionals will perform thorough physical exams and assessments throughout the trial.

Cardiovascular disease remains the leading cause of death worldwide, often developing silently through the buildup of plaque inside the arteries – a condition known as atherosclerosis. Hightower Clinical is conducting a cardiovascular prevention clinical trial aimed at identifying and reducing the risk of heart attacks and strokes in individuals who are at higher cardiovascular risk.

Participation in this study is voluntary, free of charge, and open to adults aged 55 and older who have conditions such as diabetes, prediabetes, or metabolic syndrome but no known symptoms of heart disease.

Participants will be randomly assigned to a Control group (receiving standard preventive care) or an Experimental group (receiving an imaging-based, personalized prevention plan). Throughout the study, participants will receive advanced imaging assessments, regular health evaluations, and expert care from experienced cardiovascular specialists.

Hypertension, or high blood pressure, is a common yet serious condition that increases the risk of heart disease, stroke, and kidney damage. Hightower Clinical is conducting a hypertension clinical trial in Oklahoma City to study an investigational, pacemaker-based treatment designed to help regulate blood pressure in individuals with essential or systolic hypertension.

Participation in this clinical study is voluntary, completely free of charge, and open to adults aged 18 and older who either have or are receiving a dual-chamber pacemaker.

Participants will be randomly assigned to a Control group (receiving standard pacemaker settings) or an Experimental group (receiving investigational pacing therapy). Throughout the study, you’ll receive expert care and close monitoring from experienced cardiovascular physicians as we work together to advance the future of hypertension treatment.

Explore the Librexia Stroke clinical trials in Oklahoma City, OK, where you can help advance research for effective stroke management. Stroke remains a leading cause of mortality and disability, highlighting the urgent need for improved treatments. Hightower Clinical is conducting a Phase 3 study to evaluate an investigational drug’s safety and efficacy for stroke survivors. Participation is free of cost and voluntary, with comprehensive care provided by expert physicians. Don’t miss your chance to make a difference—fill out the form to learn more about your eligibility today!